ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Factor Xa Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-38D18838
Home | Market Reports | Health| Pharmacy
Global Factor Xa Market Research Report 2025
BUY CHAPTERS

Global Factor Xa Market Research Report 2025

Code: QYRE-Auto-38D18838
Report
March 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sigma-aldrich
Roche
Abcam
MyBioSource.com
Enzo Life Sciences
Astrazeneca plc
New England Biolabs
Portola Pharmaceuticals
Promega
R&D Systems

Factor Xa Market Size

The global market for Factor Xa was valued at US$ 43.1 million in the year 2024 and is projected to reach a revised size of US$ 60.5 million by 2031, growing at a CAGR of 5.1% during the forecast period.

Factor Xa Market

Factor Xa Market

Factor Xa is a serine protease, which means it belongs to a class of enzymes that use a serine residue in their active site to carry out proteolytic cleavage. It is formed by the activation of factor X, which can occur through either the intrinsic or extrinsic pathways of the coagulation cascade.
North American market for Factor Xa is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Factor Xa is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Factor Xa include Sigma-Aldrich, Roche, Abcam, MyBioSource.com, Enzo Life Sciences, AstraZeneca, New England Biolabs, Portola Pharmaceuticals, Promega, R&D Systems, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Factor Xa, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Factor Xa.
The Factor Xa market size, estimations, and forecasts are provided in terms of sales volume (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Factor Xa market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Factor Xa manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Factor Xa Market Report

Report Metric Details
Report Name Factor Xa Market
Accounted market size in year US$ 43.1 million
Forecasted market size in 2031 US$ 60.5 million
CAGR 5.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Medical
  • Bioengineering
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sigma-Aldrich, Roche, Abcam, MyBioSource.com, Enzo Life Sciences, AstraZeneca, New England Biolabs, Portola Pharmaceuticals, Promega, R&D Systems
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Factor Xa manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Factor Xa in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Factor Xa Market growing?

Ans: The Factor Xa Market witnessing a CAGR of 5.1% during the forecast period 2025-2031.

What is the Factor Xa Market size in 2031?

Ans: The Factor Xa Market size in 2031 will be US$ 60.5 million.

Who are the main players in the Factor Xa Market report?

Ans: The main players in the Factor Xa Market are Sigma-Aldrich, Roche, Abcam, MyBioSource.com, Enzo Life Sciences, AstraZeneca, New England Biolabs, Portola Pharmaceuticals, Promega, R&D Systems

What are the Application segmentation covered in the Factor Xa Market report?

Ans: The Applications covered in the Factor Xa Market report are Medical, Bioengineering

What are the Type segmentation covered in the Factor Xa Market report?

Ans: The Types covered in the Factor Xa Market report are Human Sources, Animal Sources

Recommended Reports

Coagulation Diagnostics

Hemostasis Therapeutics

Recombinant Products

1 Factor Xa Market Overview
1.1 Product Definition
1.2 Factor Xa by Type
1.2.1 Global Factor Xa Market Value Comparison by Type (2024 VS 2031)
1.2.2 Human Sources
1.2.3 Animal Sources
1.3 Factor Xa by Application
1.3.1 Global Factor Xa Market Value by Application (2024 VS 2031)
1.3.2 Medical
1.3.3 Bioengineering
1.4 Global Factor Xa Market Size Estimates and Forecasts
1.4.1 Global Factor Xa Revenue 2020-2031
1.4.2 Global Factor Xa Sales 2020-2031
1.4.3 Global Factor Xa Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Factor Xa Market Competition by Manufacturers
2.1 Global Factor Xa Sales Market Share by Manufacturers (2020-2025)
2.2 Global Factor Xa Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Factor Xa Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Factor Xa, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Factor Xa, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Factor Xa, Product Type & Application
2.7 Global Key Manufacturers of Factor Xa, Date of Enter into This Industry
2.8 Global Factor Xa Market Competitive Situation and Trends
2.8.1 Global Factor Xa Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Factor Xa Players Market Share by Revenue
2.8.3 Global Factor Xa Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Factor Xa Market Scenario by Region
3.1 Global Factor Xa Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Factor Xa Sales by Region: 2020-2031
3.2.1 Global Factor Xa Sales by Region: 2020-2025
3.2.2 Global Factor Xa Sales by Region: 2026-2031
3.3 Global Factor Xa Revenue by Region: 2020-2031
3.3.1 Global Factor Xa Revenue by Region: 2020-2025
3.3.2 Global Factor Xa Revenue by Region: 2026-2031
3.4 North America Factor Xa Market Facts & Figures by Country
3.4.1 North America Factor Xa Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Factor Xa Sales by Country (2020-2031)
3.4.3 North America Factor Xa Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Factor Xa Market Facts & Figures by Country
3.5.1 Europe Factor Xa Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Factor Xa Sales by Country (2020-2031)
3.5.3 Europe Factor Xa Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Factor Xa Market Facts & Figures by Region
3.6.1 Asia Pacific Factor Xa Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Factor Xa Sales by Region (2020-2031)
3.6.3 Asia Pacific Factor Xa Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Factor Xa Market Facts & Figures by Country
3.7.1 Latin America Factor Xa Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Factor Xa Sales by Country (2020-2031)
3.7.3 Latin America Factor Xa Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Factor Xa Market Facts & Figures by Country
3.8.1 Middle East and Africa Factor Xa Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Factor Xa Sales by Country (2020-2031)
3.8.3 Middle East and Africa Factor Xa Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Factor Xa Sales by Type (2020-2031)
4.1.1 Global Factor Xa Sales by Type (2020-2025)
4.1.2 Global Factor Xa Sales by Type (2026-2031)
4.1.3 Global Factor Xa Sales Market Share by Type (2020-2031)
4.2 Global Factor Xa Revenue by Type (2020-2031)
4.2.1 Global Factor Xa Revenue by Type (2020-2025)
4.2.2 Global Factor Xa Revenue by Type (2026-2031)
4.2.3 Global Factor Xa Revenue Market Share by Type (2020-2031)
4.3 Global Factor Xa Price by Type (2020-2031)
5 Segment by Application
5.1 Global Factor Xa Sales by Application (2020-2031)
5.1.1 Global Factor Xa Sales by Application (2020-2025)
5.1.2 Global Factor Xa Sales by Application (2026-2031)
5.1.3 Global Factor Xa Sales Market Share by Application (2020-2031)
5.2 Global Factor Xa Revenue by Application (2020-2031)
5.2.1 Global Factor Xa Revenue by Application (2020-2025)
5.2.2 Global Factor Xa Revenue by Application (2026-2031)
5.2.3 Global Factor Xa Revenue Market Share by Application (2020-2031)
5.3 Global Factor Xa Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sigma-Aldrich
6.1.1 Sigma-Aldrich Company Information
6.1.2 Sigma-Aldrich Description and Business Overview
6.1.3 Sigma-Aldrich Factor Xa Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sigma-Aldrich Factor Xa Product Portfolio
6.1.5 Sigma-Aldrich Recent Developments/Updates
6.2 Roche
6.2.1 Roche Company Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche Factor Xa Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Roche Factor Xa Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Abcam
6.3.1 Abcam Company Information
6.3.2 Abcam Description and Business Overview
6.3.3 Abcam Factor Xa Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Abcam Factor Xa Product Portfolio
6.3.5 Abcam Recent Developments/Updates
6.4 MyBioSource.com
6.4.1 MyBioSource.com Company Information
6.4.2 MyBioSource.com Description and Business Overview
6.4.3 MyBioSource.com Factor Xa Sales, Revenue and Gross Margin (2020-2025)
6.4.4 MyBioSource.com Factor Xa Product Portfolio
6.4.5 MyBioSource.com Recent Developments/Updates
6.5 Enzo Life Sciences
6.5.1 Enzo Life Sciences Company Information
6.5.2 Enzo Life Sciences Description and Business Overview
6.5.3 Enzo Life Sciences Factor Xa Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Enzo Life Sciences Factor Xa Product Portfolio
6.5.5 Enzo Life Sciences Recent Developments/Updates
6.6 AstraZeneca
6.6.1 AstraZeneca Company Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Factor Xa Sales, Revenue and Gross Margin (2020-2025)
6.6.4 AstraZeneca Factor Xa Product Portfolio
6.6.5 AstraZeneca Recent Developments/Updates
6.7 New England Biolabs
6.7.1 New England Biolabs Company Information
6.7.2 New England Biolabs Description and Business Overview
6.7.3 New England Biolabs Factor Xa Sales, Revenue and Gross Margin (2020-2025)
6.7.4 New England Biolabs Factor Xa Product Portfolio
6.7.5 New England Biolabs Recent Developments/Updates
6.8 Portola Pharmaceuticals
6.8.1 Portola Pharmaceuticals Company Information
6.8.2 Portola Pharmaceuticals Description and Business Overview
6.8.3 Portola Pharmaceuticals Factor Xa Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Portola Pharmaceuticals Factor Xa Product Portfolio
6.8.5 Portola Pharmaceuticals Recent Developments/Updates
6.9 Promega
6.9.1 Promega Company Information
6.9.2 Promega Description and Business Overview
6.9.3 Promega Factor Xa Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Promega Factor Xa Product Portfolio
6.9.5 Promega Recent Developments/Updates
6.10 R&D Systems
6.10.1 R&D Systems Company Information
6.10.2 R&D Systems Description and Business Overview
6.10.3 R&D Systems Factor Xa Sales, Revenue and Gross Margin (2020-2025)
6.10.4 R&D Systems Factor Xa Product Portfolio
6.10.5 R&D Systems Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Factor Xa Industry Chain Analysis
7.2 Factor Xa Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Factor Xa Production Mode & Process Analysis
7.4 Factor Xa Sales and Marketing
7.4.1 Factor Xa Sales Channels
7.4.2 Factor Xa Distributors
7.5 Factor Xa Customer Analysis
8 Factor Xa Market Dynamics
8.1 Factor Xa Industry Trends
8.2 Factor Xa Market Drivers
8.3 Factor Xa Market Challenges
8.4 Factor Xa Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sigma-aldrich
Roche
Abcam
MyBioSource.com
Enzo Life Sciences
Astrazeneca plc
New England Biolabs
Portola Pharmaceuticals
Promega
R&D Systems
List of Tables
 Table 1. Global Factor Xa Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Factor Xa Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Factor Xa Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Factor Xa Sales (kg) of Key Manufacturers (2020-2025)
 Table 5. Global Factor Xa Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Factor Xa Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Factor Xa Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Factor Xa Average Price (US$/g) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Factor Xa, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Factor Xa, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Factor Xa, Product Type & Application
 Table 12. Global Key Manufacturers of Factor Xa, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Factor Xa by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Factor Xa as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Factor Xa Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Factor Xa Sales by Region (2020-2025) & (kg)
 Table 18. Global Factor Xa Sales Market Share by Region (2020-2025)
 Table 19. Global Factor Xa Sales by Region (2026-2031) & (kg)
 Table 20. Global Factor Xa Sales Market Share by Region (2026-2031)
 Table 21. Global Factor Xa Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Factor Xa Revenue Market Share by Region (2020-2025)
 Table 23. Global Factor Xa Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Factor Xa Revenue Market Share by Region (2026-2031)
 Table 25. North America Factor Xa Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Factor Xa Sales by Country (2020-2025) & (kg)
 Table 27. North America Factor Xa Sales by Country (2026-2031) & (kg)
 Table 28. North America Factor Xa Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Factor Xa Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Factor Xa Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Factor Xa Sales by Country (2020-2025) & (kg)
 Table 32. Europe Factor Xa Sales by Country (2026-2031) & (kg)
 Table 33. Europe Factor Xa Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Factor Xa Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Factor Xa Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Factor Xa Sales by Region (2020-2025) & (kg)
 Table 37. Asia Pacific Factor Xa Sales by Region (2026-2031) & (kg)
 Table 38. Asia Pacific Factor Xa Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Factor Xa Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Factor Xa Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Factor Xa Sales by Country (2020-2025) & (kg)
 Table 42. Latin America Factor Xa Sales by Country (2026-2031) & (kg)
 Table 43. Latin America Factor Xa Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Factor Xa Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Factor Xa Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Factor Xa Sales by Country (2020-2025) & (kg)
 Table 47. Middle East and Africa Factor Xa Sales by Country (2026-2031) & (kg)
 Table 48. Middle East and Africa Factor Xa Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Factor Xa Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Factor Xa Sales (kg) by Type (2020-2025)
 Table 51. Global Factor Xa Sales (kg) by Type (2026-2031)
 Table 52. Global Factor Xa Sales Market Share by Type (2020-2025)
 Table 53. Global Factor Xa Sales Market Share by Type (2026-2031)
 Table 54. Global Factor Xa Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Factor Xa Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Factor Xa Revenue Market Share by Type (2020-2025)
 Table 57. Global Factor Xa Revenue Market Share by Type (2026-2031)
 Table 58. Global Factor Xa Price (US$/g) by Type (2020-2025)
 Table 59. Global Factor Xa Price (US$/g) by Type (2026-2031)
 Table 60. Global Factor Xa Sales (kg) by Application (2020-2025)
 Table 61. Global Factor Xa Sales (kg) by Application (2026-2031)
 Table 62. Global Factor Xa Sales Market Share by Application (2020-2025)
 Table 63. Global Factor Xa Sales Market Share by Application (2026-2031)
 Table 64. Global Factor Xa Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Factor Xa Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Factor Xa Revenue Market Share by Application (2020-2025)
 Table 67. Global Factor Xa Revenue Market Share by Application (2026-2031)
 Table 68. Global Factor Xa Price (US$/g) by Application (2020-2025)
 Table 69. Global Factor Xa Price (US$/g) by Application (2026-2031)
 Table 70. Sigma-Aldrich Company Information
 Table 71. Sigma-Aldrich Description and Business Overview
 Table 72. Sigma-Aldrich Factor Xa Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 73. Sigma-Aldrich Factor Xa Product
 Table 74. Sigma-Aldrich Recent Developments/Updates
 Table 75. Roche Company Information
 Table 76. Roche Description and Business Overview
 Table 77. Roche Factor Xa Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 78. Roche Factor Xa Product
 Table 79. Roche Recent Developments/Updates
 Table 80. Abcam Company Information
 Table 81. Abcam Description and Business Overview
 Table 82. Abcam Factor Xa Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 83. Abcam Factor Xa Product
 Table 84. Abcam Recent Developments/Updates
 Table 85. MyBioSource.com Company Information
 Table 86. MyBioSource.com Description and Business Overview
 Table 87. MyBioSource.com Factor Xa Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 88. MyBioSource.com Factor Xa Product
 Table 89. MyBioSource.com Recent Developments/Updates
 Table 90. Enzo Life Sciences Company Information
 Table 91. Enzo Life Sciences Description and Business Overview
 Table 92. Enzo Life Sciences Factor Xa Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 93. Enzo Life Sciences Factor Xa Product
 Table 94. Enzo Life Sciences Recent Developments/Updates
 Table 95. AstraZeneca Company Information
 Table 96. AstraZeneca Description and Business Overview
 Table 97. AstraZeneca Factor Xa Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 98. AstraZeneca Factor Xa Product
 Table 99. AstraZeneca Recent Developments/Updates
 Table 100. New England Biolabs Company Information
 Table 101. New England Biolabs Description and Business Overview
 Table 102. New England Biolabs Factor Xa Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 103. New England Biolabs Factor Xa Product
 Table 104. New England Biolabs Recent Developments/Updates
 Table 105. Portola Pharmaceuticals Company Information
 Table 106. Portola Pharmaceuticals Description and Business Overview
 Table 107. Portola Pharmaceuticals Factor Xa Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 108. Portola Pharmaceuticals Factor Xa Product
 Table 109. Portola Pharmaceuticals Recent Developments/Updates
 Table 110. Promega Company Information
 Table 111. Promega Description and Business Overview
 Table 112. Promega Factor Xa Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 113. Promega Factor Xa Product
 Table 114. Promega Recent Developments/Updates
 Table 115. R&D Systems Company Information
 Table 116. R&D Systems Description and Business Overview
 Table 117. R&D Systems Factor Xa Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 118. R&D Systems Factor Xa Product
 Table 119. R&D Systems Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Factor Xa Distributors List
 Table 123. Factor Xa Customers List
 Table 124. Factor Xa Market Trends
 Table 125. Factor Xa Market Drivers
 Table 126. Factor Xa Market Challenges
 Table 127. Factor Xa Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Factor Xa
 Figure 2. Global Factor Xa Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Factor Xa Market Share by Type: 2024 & 2031
 Figure 4. Human Sources Product Picture
 Figure 5. Animal Sources Product Picture
 Figure 6. Global Factor Xa Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Factor Xa Market Share by Application: 2024 & 2031
 Figure 8. Medical
 Figure 9. Bioengineering
 Figure 10. Global Factor Xa Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Factor Xa Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Factor Xa Sales (2020-2031) & (kg)
 Figure 13. Global Factor Xa Average Price (US$/g) & (2020-2031)
 Figure 14. Factor Xa Report Years Considered
 Figure 15. Factor Xa Sales Share by Manufacturers in 2024
 Figure 16. Global Factor Xa Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Factor Xa Players: Market Share by Revenue in Factor Xa in 2024
 Figure 18. Factor Xa Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Factor Xa Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Factor Xa Sales Market Share by Country (2020-2031)
 Figure 21. North America Factor Xa Revenue Market Share by Country (2020-2031)
 Figure 22. United States Factor Xa Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Factor Xa Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Factor Xa Sales Market Share by Country (2020-2031)
 Figure 25. Europe Factor Xa Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Factor Xa Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Factor Xa Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Factor Xa Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Factor Xa Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Factor Xa Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Factor Xa Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Factor Xa Revenue Market Share by Region (2020-2031)
 Figure 33. China Factor Xa Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Factor Xa Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Factor Xa Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Factor Xa Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Factor Xa Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Factor Xa Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Factor Xa Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Factor Xa Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Factor Xa Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Factor Xa Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Factor Xa Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Factor Xa Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Colombia Factor Xa Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Factor Xa Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Factor Xa Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Factor Xa Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Factor Xa Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Factor Xa Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Factor Xa by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Factor Xa by Type (2020-2031)
 Figure 53. Global Factor Xa Price (US$/g) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Factor Xa by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Factor Xa by Application (2020-2031)
 Figure 56. Global Factor Xa Price (US$/g) by Application (2020-2031)
 Figure 57. Factor Xa Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Thrombin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Coagulation Factor VII Market Insights Forecast to 2030
Global Serine Protease Market Insights Forecast to 2030
Global Factor Xa Inhibitors Market Research Report 2024
Coagulation Factors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmaceutical Serine Protease Market Research Report 2025
Global Factor IX Deficiency Treatment Market Research Report 2024
Protease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Activated Coagulation Factor VII Market Research Report 2025
Antithrombin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Factor Xa Inhibitors Market Research Report 2024
Coagulation Factor IX Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Elastase Market Insights Forecast to 2030
Global FXa Inhibitor Market Research Report 2025
Global Clotting Factor Market Research Report 2025
Global Milk Coagulating Enzyme Market Research Report 2024
Humanes Antithrombin III Konzentrat Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tranexamic Acid Market Research Report 2025
Coagulation Factor VIIa Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tissue Plasminogen Activator Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions